A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in <i>in vivo</i> and <i>ex vivo</i> models
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Phurin Areesawangkit
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Karen Pei-Yi Fong
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Emma Niemeyer
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Yan Li
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Kelly Markowitz
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Devora Delman
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Ryan Krause
raw_affiliation_strings: Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Justine Carl
raw_affiliation_strings: Incyte Corporation
raw_author_name: Pat Feldman
raw_affiliation_strings: Incyte Corporation
raw_author_name: Lisa Troung
raw_affiliation_strings: Incyte Corporation
raw_author_name: Rodrigo Hess
raw_affiliation_strings: Incyte Corporation
raw_author_name: Xiaodi Ren
raw_affiliation_strings: Incyte Corporation
raw_author_name: Cynthia Timmers
raw_affiliation_strings: Incyte Corporation
raw_author_name: Sunkyu Kim
raw_affiliation_strings: Incyte Corporation
raw_author_name: Robert Brody
raw_affiliation_strings: Department of Otorhinolaryngology, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Sunil Singhal
raw_affiliation_strings: Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Jarrod Predina
raw_affiliation_strings: Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Evgeniy Eruslanov
raw_affiliation_strings: Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Gregory Beatty
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
raw_author_name: Bihui Melidosian
raw_affiliation_strings: Incyte Corporation
raw_author_name: Steven M. Albelda
raw_affiliation_strings: Center for Cellular Immunology, Perelman School of Medicine, University of Pennsylvania
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania